A model for care across the cancer continuum

Cancer

Volumn 104, Issue 11 SUPPL., 2005, Pages 2638-2642

  Hudson, Melissa M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Childhood cancer; Childhood cancer survivors; Followup care; Health care; Late effects; Prevention; Quality of life

Indexed keywords

CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURVIVAL; CHILD; CHILD HEALTH CARE; CHILDHOOD CANCER; CONFERENCE PAPER; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH EDUCATION; HUMAN; MODEL; MORBIDITY; ONCOLOGY; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CHILD; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; RADIOTHERAPY; SURVIVORS;

EID: 28044452426     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21250     Document Type: Conference Paper

References (27)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
2. Ries LAG, Eisner MP, Kosay CL, et al., editors. SEER Cancer Statistics Review, 1975-2002. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/esr/1975_2002/[Accessed September 12, 2005].
3. Garre ML, Gandus S, Cesana B, et al. Health status of long-term survivors after cancer in childhood. Results of a multiinstitutional study in Italy. Am J Pediatr Hematol Oncol. 1994;16:143-152.
4. Vonderweid N, Beck D, Caflisch U, et al. Standardized assessment of late effects in long-term survivors of childhood cancer in Switzerland: results of a Swiss Pediatric Oncology Group (SPOG) pilot study. Int J Pediatr Hematol Oncol. 1996;3:483-490.
5. Stevens MCG, Mahler H, Parks S. The health status of adult survivors of cancer in childhood. Eur J Cancer. 1998;34:694-698.
6. Oeffinger KC, Eshelman DA, Tomlinson GE, et al. Grading of late effects in young adult cancer survivors of childhood cancer following in an ambulatory adult setting. Cancer. 2000;88:1687-1695.
7. Hudson MM, Jones D, Boyett J, et al. Late mortality of long-term survivors of childhood cancer. J Clin Oncol. 1997;15:2205-2213.
8. Hudson MM, Poquette CA, Lee J, et al. Increased mortality after successful treatment for Hodgkin's disease. J Clin Oncol. 1998;16:3592-3600.
9. Green DM, Hyland A, Chung CS, et al. Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence. J Clin Oncol. 1999;17:3207-3215.
10. Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2001;19:3163-3172.
11. Donaldson SS. Pediatric patients: tolerance levels and effects of treatment. Front Radiat Ther Oncol. 1989;23:390-407.
12. Byrne J, Fears TR, Gail MH, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992;166:788-793.
13. Mefferd JM, Donaldson SS, Link MP. Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys. 1989;16:679-685.
14. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol. 1993;11:1208-1215.
15. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324:808-815.
16. Lipshultz SE, Lipsitz SR, Mone SM, et al. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med. 1995;332:1738-1743.
17. Kreisman H, Wolkove N. Pulmonary toxicity of antineoplastic therapy. Semin Oncol. 1992;19:508-520.
18. Meadows AT, Obringer AC, Marrero O, et al. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors. Med Pediatr Oncol. 1989;17:477-484.
19. Hawkins MM, Kinnier Wilson LM, Stovall MA, et al. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukemia after childhood cancer. Br Med J. 1992;304:951-958.
20. Sankila R, Garwicz S, Olsen JH, et al. Risk of subsequent malignant neoplasms among 1641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. J Clin Oncol. 1996;14:1442-1446.
21. van Leeuwen FE, Klokman WI, van't Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol. 2000;18:487-497.
22. Swerdlow AJ, Barber JA, Vaughan Hudson G, et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol. 2000;18:498-09.
23. Green DM, Hyland A, Barcos MP, et al. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol. 2000;18:1492-1499.
24. Metayer C, Lynch CF, Clarke EA, et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol. 2000;18:2435-2443.
25. Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 1996;334:745-751.
26. Wolden SL, Lamborn KR, Cleary SF, et al. Second cancers following pediatric Hodgkin's disease. J Clin Oncol. 1998;16:536-544.
27. Hudson MM, Donaldson SS. Treatment of pediatric lymphoma. Semin Hematol. 1999;36:313-323.